Home> Products> precise dosing mechanism

{ "products": [ { "_id": "6979b09d927481ba212bc573", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Tedizolid Phosphate 200 mg ", "description": "TEDIZOLINE 200 is a state-of-the-art pharmaceutical formulation containing Tedizolid Phosphate 200 mg, representing a significant advancement in the treatment of serious bacterial skin infections. This next-generation oxazolidinone antibiotic offers a powerful solution for patients battling acute bacterial skin and skin structure infections (ABSSSI), including those caused by methicillin-resistant Staphylococcus aureus (MRSA) and other resistant bacterial strains. Developed to address the growing challenge of antibiotic resistance, TEDIZOLINE 200 provides healthcare professionals with an effective therapeutic option when conventional antibiotics may fall short.\nThe active ingredient, Tedizolid Phosphate, functions as a prodrug that is rapidly converted in the body to its active form, tedizolid. This sophisticated mechanism ensures optimal bioavailability and targeted antibacterial action. Each tablet of TEDIZOLINE 200 delivers a precise 200 mg dose, carefully calibrated to provide maximum efficacy while minimizing the risk of adverse effects. The medication is available in convenient oral tablet form, offering flexibility in treatment administration and improving patient compliance compared to intravenous-only alternatives.\nClinical Applications and Therapeutic Uses\nTEDIZOLINE 200 is specifically indicated for the treatment of acute bacterial skin and skin structure infections caused by susceptible strains of various gram-positive bacteria. These infections include cellulitis, major cutaneous abscesses, and wound infections that require systemic antibiotic therapy. The medication demonstrates exceptional efficacy against problematic pathogens including Staphylococcus aureus (both methicillin-susceptible and methicillin-resistant strains), various Streptococcus species, and Enterococcus faecalis.\nHealthcare providers prescribe TEDIZOLINE 200 when patients present with complicated skin infections characterized by significant inflammation, purulent discharge, or systemic signs of infection such as fever and elevated white blood cell counts. The medication is particularly valuable in hospital settings where antibiotic-resistant organisms pose significant treatment challenges, though it is equally effective for outpatient management of appropriate cases.\nThe standard treatment duration with TEDIZOLINE 200 is notably shorter than many traditional antibiotics, typically requiring only six days of therapy. This abbreviated course represents a significant advantage, potentially improving patient adherence, reducing the risk of developing resistance, and minimizing healthcare costs while maintaining excellent clinical outcomes.\nKey Benefits and Therapeutic Advantages\nSuperior Antimicrobial Potency: TEDIZOLINE 200 exhibits exceptional bactericidal activity against resistant gram-positive organisms, making it a frontline weapon against infections that have failed to respond to first-line antibiotics. Its unique mechanism of action—inhibiting bacterial protein synthesis by binding to the 23S ribosomal RNA of the 50S subunit—prevents bacteria from producing essential proteins necessary for survival and reproduction.\nShortened Treatment Duration: Unlike conventional antibiotics that may require ten to fourteen days of therapy, TEDIZOLINE 200 achieves comparable or superior outcomes with just six days of treatment. This condensed regimen reduces the pill burden for patients, improves treatment completion rates, and decreases the opportunity for resistance development.\nFlexible Administration Options: The medication offers both oral and intravenous formulations with nearly identical bioavailability, allowing seamless transitions between routes of administration. This flexibility enables early hospital discharge with continuation of oral therapy at home, reducing healthcare costs and improving patient comfort and quality of life.\nOnce-Daily Dosing Convenience: TEDIZOLINE 200's pharmacokinetic profile supports convenient once-daily administration, simplifying treatment schedules and enhancing patient compliance. The sustained therapeutic levels achieved with this dosing frequency ensure continuous antibacterial activity throughout the treatment course.\nReduced Drug Interaction Profile: Compared to its predecessor oxazolidinone antibiotics, TEDIZOLINE 200 demonstrates minimal interactions with dietary tyramine and requires less stringent dietary restrictions. Additionally, it exhibits reduced potential for serotonin syndrome, offering improved safety when used in patients taking certain antidepressants or other serotonergic medications.\nProven Clinical Efficacy: Extensive clinical trials have demonstrated that TEDIZOLINE 200 achieves cure rates comparable to or exceeding those of vancomycin and linezolid, the traditional gold standards for treating MRSA infections. These studies confirm both the non-inferiority and, in some parameters, the superiority of tedizolid phosphate in treating complicated skin infections.\nPotential Side Effects and Safety Considerations\nWhile TEDIZOLINE 200 is generally well-tolerated, patients and healthcare providers should be aware of potential adverse effects. The most commonly reported side effects include nausea, headache, diarrhea, and vomiting, which typically manifest as mild to moderate in severity and often resolve without intervention.\nGastrointestinal disturbances affect approximately five to ten percent of patients, with nausea being the most frequent complaint. Taking the medication with food may help minimize these symptoms without compromising absorption. Headaches occur in a similar percentage of patients and usually respond well to over-the-counter analgesics.\nMore serious but less common adverse effects include myelosuppression, manifesting as decreased blood cell counts. Although TEDIZOLINE 200 demonstrates less bone marrow suppression than older oxazolidinones, monitoring of complete blood counts is recommended for treatment courses extending beyond the standard six days or in patients with pre-existing hematologic conditions.\nPeripheral and optic neuropathy have been reported with prolonged oxazolidinone use, though the shorter treatment duration of TEDIZOLINE 200 substantially reduces this risk. Patients should report any vision changes, numbness, tingling, or weakness in extremities promptly to their healthcare provider.\nClostridium difficile-associated diarrhea can occur with virtually any antibiotic, including TEDIZOLINE 200. Patients experiencing severe, persistent, or bloody diarrhea during or following treatment should seek immediate medical attention.\nHypersensitivity reactions, though rare, may occur and can range from mild rash to severe anaphylaxis. Any signs of allergic reaction warrant immediate discontinuation and appropriate medical intervention.\nConclusion\nTEDIZOLINE 200 represents a significant therapeutic advancement in the management of acute bacterial skin and skin structure infections, particularly those involving antibiotic-resistant organisms. Its potent antimicrobial activity, convenient once-daily dosing, shortened treatment duration, and improved safety profile compared to earlier oxazolidinones make it an invaluable addition to the antimicrobial arsenal. The medication addresses critical unmet needs in infectious disease management, offering effective treatment options when traditional antibiotics prove insufficient.", "price": 1250.0, "discountamount": 375.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2288, "imageuri": "https://productimages.withfloats.com/actual/6979b0c4b75d7c0b79b08e15.png", "tileimageuri": "https://productimages.withfloats.com/tile/6979b0c4b75d7c0b79b08e15.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-28T06:45:49.837Z", "updatedon": "2026-01-28T12:11:25Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tedizolid-phosphate-200-mg-/2288", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TEDIZOLINE 200", "category": "DERMATALOGY", "tags": [ "tedizolid phosphate 200 mg tablet", "tedizolid phosphate 200 mg uses", "tedizolid phosphate 200 mg dosage", "tedizolid phosphate tablets 200 mg price", "tedizolid phosphate 200 mg side effects", "tedizolid phosphate 200 mg brand name", "tedizolid phosphate 200 mg mechanism of action", "buy tedizolid phosphate 200 mg tablet", "tedizolid phosphate 200 mg prescription info", "tedizolid phosphate 200 mg tablet details", "tedizolid phosphate 200 mg for skin infection", "tedizolid phosphate 200 mg once daily tablet", "tedizolid phosphate 200 mg tablet working" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69662101a96bbf383231d700", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "FABRICAL MG K₂7", "description": "FABRICAL MG K₂7 represents a scientifically advanced nutritional supplement that combines essential minerals and vitamins in a synergistic formulation designed to support optimal bone health, cardiovascular function, and overall metabolic wellness. This innovative product brings together six critical nutrients—Calcium Citrate Maleate, Magnesium Bisglycinate, Vitamin D3, Vitamin K2-7 (Menaquinone-7), Zinc, and Methylcobalamin—in precise therapeutic ratios that maximize bioavailability and clinical effectiveness.\nUnlike conventional calcium supplements that focus solely on calcium supplementation, FABRICAL MG K₂7 adopts a comprehensive, multi-nutrient approach that addresses the complex interplay between various micronutrients essential for skeletal integrity, neuromuscular function, immune competence, and metabolic regulation. This sophisticated formulation reflects current understanding of nutritional biochemistry, recognizing that optimal health outcomes require balanced supplementation rather than isolated nutrient provision.\nThe product has been meticulously formulated to address the growing epidemic of nutritional deficiencies affecting diverse populations, from elderly individuals experiencing age-related bone loss to young adults with suboptimal dietary intake, pregnant women with increased nutritional demands, and individuals with chronic conditions affecting nutrient absorption or utilization. FABRICAL MG K₂7 serves as a convenient, evidence-based solution for maintaining nutritional adequacy and supporting long-term health across various life stages.\nDetailed Understanding of FABRICAL MG K₂7 Components\nCalcium Citrate Maleate: Superior Calcium Bioavailability\nCalcium Citrate Maleate represents the premium form of calcium supplementation, offering significantly enhanced absorption compared to traditional calcium carbonate. This advanced calcium complex demonstrates approximately 25-30% better bioavailability, making it particularly valuable for individuals with reduced gastric acid production, including elderly populations and those taking proton pump inhibitors or H2-receptor antagonists. Unlike calcium carbonate, which requires acidic conditions for optimal dissolution, Calcium Citrate Maleate can be absorbed efficiently regardless of meal timing or stomach pH, providing greater flexibility and convenience.\nThe maleate component further enhances calcium absorption and utilization by supporting cellular energy metabolism and mitochondrial function. This sophisticated formulation ensures that supplemented calcium reaches target tissues—bones, teeth, muscles, and nerves—where it performs essential physiological functions rather than accumulating in soft tissues where it could potentially contribute to unwanted calcification.\nMagnesium Bisglycinate: The Gentle Magnesium Choice\nMagnesium Bisglycinate, also known as magnesium glycinate, stands as one of the most bioavailable and well-tolerated forms of magnesium supplementation. This chelated form, where magnesium is bound to two molecules of the amino acid glycine, offers exceptional absorption rates approaching 80-90% while minimizing the gastrointestinal side effects—particularly diarrhea—commonly associated with other magnesium forms like magnesium oxide or sulfate.\nMagnesium plays over 300 enzymatic roles throughout the body, making it indispensable for energy production, protein synthesis, muscle and nerve function, blood glucose control, and blood pressure regulation. Within FABRICAL MG K₂7, magnesium works synergistically with calcium, maintaining the critical calcium-magnesium balance essential for proper muscular contraction and relaxation, cardiovascular rhythm stability, and skeletal mineralization.\nVitamin D3: The Sunshine Vitamin in Its Active Form\nVitamin D3 (cholecalciferol) represents the most bioactive form of vitamin D, identical to what human skin synthesizes upon ultraviolet B exposure. This fat-soluble vitamin functions more accurately as a hormone, regulating calcium absorption from the intestines, maintaining serum calcium and phosphorus concentrations within optimal ranges, and modulating bone remodeling by both osteoblasts and osteoclasts.\nBeyond skeletal functions, Vitamin D3 exerts profound influences on immune system regulation, cellular differentiation and proliferation, neuromuscular function, and inflammation modulation. Vitamin D receptors exist throughout the body—in tissues ranging from the brain and heart to immune cells and muscle—highlighting its systemic importance. The inclusion of Vitamin D3 in FABRICAL MG K₂7 ensures that supplemented calcium can be effectively absorbed and utilized, preventing the futility of calcium supplementation in vitamin D-deficient states.\nVitamin K2-7: The Missing Link in Bone and Cardiovascular Health\nVitamin K2-7, specifically the menaquinone-7 (MK-7) form, represents perhaps the most revolutionary component of FABRICAL MG K₂7. This long-chain vitamin K2 demonstrates superior bioavailability and longer half-life compared to vitamin K1 (phylloquinone) found in green vegetables or shorter-chain K2 forms. Vitamin K2-7's critical function involves activating proteins responsible for proper calcium utilization—specifically matrix Gla protein (MGP) and osteocalcin.\nOsteocalcin, produced by bone-building osteoblasts, requires vitamin K2-dependent carboxylation to become active and effectively bind calcium into bone matrix, strengthening skeletal structure. Simultaneously, Vitamin K2-7 activates MGP, which prevents calcium deposition in arterial walls and soft tissues, directing calcium away from cardiovascular structures where it contributes to atherosclerosis and arterial stiffness. This dual action—promoting bone calcification while preventing vascular calcification—makes Vitamin K2-7 uniquely valuable, addressing the “calcium paradox” where individuals may simultaneously experience osteoporosis and arterial calcification.\nZinc: The Multifunctional Essential Mineral\nZinc, incorporated into FABRICAL MG K₂7 in highly bioavailable form, serves numerous critical physiological functions spanning immune competence, wound healing, protein synthesis, DNA synthesis, and cellular division. Regarding bone health specifically, zinc influences bone metabolism by supporting osteoblast activity and collagen synthesis, contributing to bone matrix formation and mineralization. Zinc also functions as a cofactor for alkaline phosphatase, an enzyme essential for bone mineralization.\nBeyond skeletal contributions, zinc supports immune system function, acting as a critical component of innumerable enzymes involved in immune cell development and function. Zinc deficiency impairs both innate and adaptive immunity, increasing susceptibility to infections. The mineral also supports sensory function (taste and smell), cognitive function, reproductive health, and skin integrity.\nMethylcobalamin: The Bioactive Vitamin B12\nMethylcobalamin represents the active, coenzyme form of vitamin B12, requiring no metabolic conversion to exert biological activity. This form demonstrates superior neurological benefits compared to cyanocobalamin, the synthetic form commonly used in supplements. Methylcobalamin directly participates in methionine synthesis and methylation reactions critical for nervous system health, DNA synthesis, red blood cell formation, and homocysteine metabolism.\nElevated homocysteine, resulting from inadequate B12 status, associates with increased cardiovascular disease risk, cognitive decline, and bone fragility. By supporting homocysteine conversion to methionine, methylcobalamin in FABRICAL MG K₂7 contributes to cardiovascular protection and potentially supports bone health through mechanisms independent of its well-established neurological and hematological roles.\nPrimary Uses and Clinical Applications of FABRICAL MG K₂7\nComprehensive Bone Health Support\nThe primary indication for FABRICAL MG K₂7 centers on comprehensive bone health support across various life stages and clinical scenarios. The formulation addresses all critical aspects of skeletal health: providing adequate calcium substrate for mineralization, ensuring calcium absorption through Vitamin D3, directing calcium into bone matrix via Vitamin K2-7, supporting bone matrix formation through magnesium and zinc, and protecting against homocysteine-related bone fragility through methylcobalamin.\nThis makes FABRICAL MG K₂7 particularly valuable for:\nOsteoporosis Prevention and Management: Postmenopausal women and elderly men experiencing age-related bone loss benefit from the formulation's comprehensive approach, potentially slowing bone density decline and reducing fracture risk.\nGrowing Children and Adolescents: During peak bone-building years, FABRICAL MG K₂7 supports optimal skeletal development, helping children and teenagers achieve maximum peak bone mass—a critical determinant of lifelong skeletal health.\nPregnancy and Lactation: Women during pregnancy and breastfeeding experience dramatically increased calcium demands. FABRICAL MG K₂7 helps prevent maternal bone density loss while supporting fetal skeletal development.\nCardiovascular Protection Through Proper Calcium Distribution\nThe Vitamin K2-7 component positions FABRICAL MG K₂7 as more than a bone health supplement—it's a cardiovascular protective formulation. By activating matrix Gla protein, the supplement helps prevent arterial calcification, potentially reducing cardiovascular disease risk. This dual benefit addresses the concerning observation that some individuals taking calcium supplements without adequate Vitamin K2 may experience increased cardiovascular events due to inappropriate calcium deposition in arterial walls.\nNeurological and Cognitive Support\nThe methylcobalamin component provides neurological support, particularly valuable for elderly individuals at risk for vitamin B12 deficiency due to reduced intrinsic factor production or those taking medications that impair B12 absorption (such as metformin or proton pump inhibitors). Adequate B12 status supports cognitive function, mood regulation, nerve conduction, and may help prevent peripheral neuropathy.\nImmune System Enhancement\nBoth zinc and vitamin D3 within FABRICAL MG K₂7 contribute significantly to immune competence. Vitamin D modulates both innate and adaptive immunity, while zinc supports immune cell development and function. This immune support proves particularly relevant during seasonal illness peaks or for individuals with compromised immunity.\nMuscle Function and Exercise Performance\nMagnesium's role in muscle contraction and relaxation, combined with calcium's involvement in excitation-contraction coupling, makes FABRICAL MG K₂7 valuable for athletes and physically active individuals. The formulation may help prevent exercise-associated muscle cramps, support recovery, and maintain electrolyte balance.\nKey Benefits of FABRICAL MG K₂7\nEnhanced Bioavailability and Absorption\nUnlike basic supplements using inferior ingredient forms, FABRICAL MG K₂7 utilizes premium, highly bioavailable compounds:\n\nCalcium Citrate Maleate offers superior absorption compared to calcium carbonate\nMagnesium Bisglycinate provides excellent absorption without gastrointestinal distress\nVitamin D3 is more potent than D2\nVitamin K2-7 (MK-7) has longer half-life and better tissue distribution than K1 or shorter-chain K2 forms\nMethylcobalamin is the active B12 form requiring no conversion\n\nThis superior bioavailability means lower doses can achieve therapeutic effects, reducing pill burden and potential adverse effects while maximizing benefits.\nSynergistic Nutrient Interactions\nFABRICAL MG K₂7's formulation recognizes that nutrients work together, not in isolation:\n\nVitamin D3 enhances calcium absorption while Vitamin K2-7 directs where that calcium goes\nMagnesium supports Vitamin D activation and calcium metabolism\nZinc supports bone matrix formation complementing calcium's role in mineralization\nMethylcobalamin supports methylation pathways that may influence bone health\n\nThis synergy delivers benefits exceeding what individual nutrients could provide separately.\nComprehensive Rather Than Fragmented Nutritional Support\nRather than requiring multiple separate supplements, FABRICAL MG K₂7 provides comprehensive support in a single, convenient formulation. This simplification improves compliance, reduces costs compared to purchasing individual supplements, and eliminates concerns about nutrient imbalances from uncoordinated supplementation.\nProtection Against the Calcium Paradox\nPerhaps the most significant benefit stems from the Vitamin K2-7 inclusion, which addresses the calcium paradox—simultaneously strengthening bones while protecting cardiovascular health by preventing arterial calcification. This represents a critical advancement over traditional calcium supplements that may inadvertently increase cardiovascular risk when taken without adequate Vitamin K2.\nSupport Across Multiple Physiological Systems\nBeyond bones, FABRICAL MG K₂7 benefits:\n\nCardiovascular System: Through arterial protection and homocysteine management\nNervous System: Via methylcobalamin's neurological support\nImmune System: Through vitamin D3 and zinc's immunomodulatory effects\nMuscular System: Via magnesium and calcium's roles in contraction\nMetabolic System: Through magnesium's involvement in glucose metabolism\n\nThis multi-system support delivers value far exceeding simple bone health supplementation.\nPotential Side Effects and Safety Considerations\nGenerally Well-Tolerated with Minimal Side Effects\nFABRICAL MG K₂7, when taken as directed, demonstrates excellent tolerability in most individuals. The selection of highly bioavailable, gentle nutrient forms specifically minimizes adverse effects common with inferior formulations.\nMild Gastrointestinal Effects\nSome users may initially experience mild digestive symptoms including:\n\nSlight nausea, particularly if taken on an empty stomach\nMinor bloating or gas\nMild constipation (though less likely than with calcium carbonate formulations)\n\nThese effects typically resolve within a few days as the body adjusts and can be minimized by taking the supplement with meals and ensuring adequate hydration.\nRare Allergic Reactions\nAlthough uncommon, some individuals may experience hypersensitivity to ingredients or excipients in the formulation. Signs include rash, itching, or swelling. Discontinuation and medical consultation are warranted if such reactions occur.\nConsiderations for Specific Populations\nIndividuals on Anticoagulants: Vitamin K2, while generally safer regarding coagulation than K1, may theoretically interact with warfarin. Patients on anticoagulation therapy should consult healthcare providers before starting FABRICAL MG K₂7, though recent evidence suggests K2 supplementation at consistent doses may not significantly affect INR stability.\nKidney Disease Patients: Individuals with chronic kidney disease should consult nephrologists before supplementing with calcium, magnesium, or vitamin D due to altered mineral metabolism and increased calcification risks in renal impairment.\nHypercalcemia Risk: Those with conditions predisposing to elevated calcium (hyperparathyroidism, sarcoidosis, certain cancers) should avoid supplementation without medical supervision.\nImportance of Appropriate Dosing\nExceeding recommended doses may increase adverse effect risks including:\n\nHypercalcemia (excessive calcium) causing nausea, constipation, kidney stones\nHypermagnesemia (excessive magnesium) causing diarrhea, cardiac abnormalities\nVitamin D toxicity (though requiring very high doses sustained over time)\n\nFollowing manufacturer's recommendations and consulting healthcare providers regarding individual needs ensures safe, effective use.\nRecommended Usage and Dosage Guidelines\nFABRICAL MG K₂7 should be taken according to manufacturer recommendations, typically one to two tablets daily with meals for optimal absorption of fat-soluble vitamins (D3 and K2-7). Taking the supplement with food containing some dietary fat further enhances absorption of these critical nutrients while minimizing potential gastrointestinal discomfort.\nConsistency in timing supports optimal benefits, as regular daily supplementation maintains stable nutrient levels. For individuals on multiple medications, spacing FABRICAL MG K₂7 administration at least two hours from certain medications (particularly thyroid hormones, bisphosphonates, or antibiotics) prevents potential absorption interference.\nIndividual requirements vary based on age, sex, dietary intake, health status, and specific deficiency risks. Healthcare provider consultation helps determine whether standard dosing suffices or whether adjustments are warranted. Periodic monitoring of vitamin D levels and other relevant biomarkers may be recommended to ensure supplementation achieves therapeutic goals without overshooting into excess.\nConclusion: FABRICAL MG K₂7 as a Comprehensive Nutritional Solution\nFABRICAL MG K₂7 stands as a sophisticated, scientifically formulated nutritional supplement that transcends traditional approaches to bone health support. By combining six synergistic nutrients in highly bioavailable forms, this innovative product addresses the complex, interconnected nature of skeletal health, cardiovascular protection, neurological function, and overall metabolic wellness.\nThe formulation's greatest strength lies in its comprehensive approach—recognizing that optimal health outcomes require balanced nutrition rather than isolated nutrient provision. The inclusion of Vitamin K2-7 particularly distinguishes FABRICAL MG K₂7 from conventional calcium supplements, addressing the critical calcium paradox and ensuring supplemented calcium strengthens bones while protecting cardiovascular structures.\nFor individuals seeking to support bone density, prevent osteoporosis, ensure adequate nutritional status during life stages of increased demand, or simply maintain optimal health through evidence-based supplementation, FABRICAL MG K₂7 offers a convenient, effective solution backed by nutritional science. Its excellent tolerability, superior ingredient quality, and multi-system benefits make it suitable for diverse populations from growing adolescents to active adults and elderly individuals concerned about age-related health challenges.\nAs with any nutritional supplement, FABRICAL MG K₂7 works best as part of a comprehensive health strategy including balanced nutrition, regular physical activity, adequate sleep, stress management, and appropriate medical care. It complements rather than replaces healthy lifestyle practices, providing nutritional insurance that helps fill gaps in modern diets while supporting long-term wellness.\nWhether you're proactively supporting your skeletal health, addressing identified nutritional deficiencies, or seeking comprehensive multi-nutrient support, FABRICAL MG K₂7 represents a premium choice that combines scientific sophistication with practical convenience, delivering measurable benefits that support vibrant health across all life stages.\n\nDisclaimer: This information is for educational purposes and does not constitute medical advice. Individual nutritional needs vary significantly based on numerous factors. Consult qualified healthcare professionals before starting any supplement regimen, particularly if you have existing health conditions, take medications, are pregnant or nursing, or have specific health concerns. Keep supplements out of reach of children and store according to manufacturer recommendations to maintain product integrity and safety.", "price": 250.0, "discountamount": 75.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2274, "imageuri": "https://productimages.withfloats.com/actual/696621081f531945cbd90a0c.png", "tileimageuri": "https://productimages.withfloats.com/tile/696621081f531945cbd90a0c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-13T10:40:01.051Z", "updatedon": "2026-02-13T07:27:00.217Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/fabrical-mg-k-7/2274", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "FABRICAL MG K₂7", "category": "ORTHOLOGYRANG", "tags": [ "calcium citrate maleate magnesium bisglycinate tablets", "calcium citrate maleate with vitamin d3 k2 mk7", "magnesium bisglycinate with methylcobalamin tablets", "calcium citrate maleate vitamin k2-7 tablets", "best calcium citrate maleate tablets for bones", "magnesium bisglycinate tablets for muscle cramps", "methylcobalamin zinc tablets for nerve health", "calcium citrate maleate tablets for osteoporosis", "best calcium supplement with k2-7 for bone strength", "vitamin k2-7 mk7 with calcium benefits", "bone strength tablets with calcium magnesium zinc", "vitamin d3 k2 calcium tablets for elderly", "calcium citrate maleate tablets price in india", "best calcium magnesium vitamin d3 k2 tablets", "best bone health tablets with vitamin k2-7", "calcium magnesium zinc methylcobalamin tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6958dbfa1063d98b1e8f2fe1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Benidipine 4mg", "description": "BENIPRIME 4, containing Benidipine 4 mg, offers effective management for high blood pressure and related heart conditions. This calcium channel blocker helps relax blood vessels to improve blood flow and reduce strain on the heart. Patients often find it reliable for daily control of hypertension symptoms.\n\nWhat is BENIPRIME 4?\nBENIPRIME 4 is a branded tablet from Steris Healthcare Pvt Ltd, featuring 4 mg of Benidipine as the active ingredient. Benidipine belongs to the dihydropyridine class of calcium channel blockers, designed specifically for cardiovascular health. Each tablet delivers a precise dose in a user-friendly form, typically packaged in strips of 10 for convenient use. Manufactured under strict quality standards, it targets essential needs in hypertension care, making it a staple in many treatment plans across India.\n​\n\nThis medication stands out due to its triple action on L-type, N-type, and T-type calcium channels, providing broader vascular protection compared to some other blockers. Doctors prescribe it for adults dealing with persistent high blood pressure or chest pain, often starting at this 4 mg strength for balanced efficacy. Unlike generic options, BENIPRIME 4 ensures consistent absorption and formulation tailored for Indian patients, with pricing around Rs 62-89 per strip after discounts.\n​\n\nHow BENIPRIME 4 Works\nBenidipine in BENIPRIME 4 blocks calcium entry into smooth muscle cells of blood vessels and heart muscles. This action causes vasodilation, widening arteries to lower resistance and ease blood flow. By reducing systolic and diastolic pressure, it lightens the heart's workload without drastically slowing the heartbeat.\n​\n\nThe unique blockade of multiple calcium channels also boosts nitric oxide production, offering antioxidant effects and protection against artery hardening. This sustained mechanism provides 24-hour control, ideal for once-daily dosing after breakfast. Over time, it may even reduce urinary protein and triglycerides, supporting kidney and metabolic health in hypertensives.\n​\n\nKey Uses of BENIPRIME 4\nBENIPRIME 4 primarily treats essential hypertension, helping prevent strokes, heart attacks, and kidney damage. It effectively manages angina pectoris by enhancing coronary blood supply, reducing chest pain episodes during activity.\n​\n\nPhysicians also use it for renal parenchymal hypertension, where kidney issues elevate blood pressure. In emergencies like hypertensive crises or subarachnoid hemorrhage, higher doses prove beneficial, though 4mg serves as maintenance. For arrhythmia or anal fissures linked to vascular strain, it offers supportive relief.\n​\n\nLowers high blood pressure in adults, including severe cases with dose adjustments.\n​\n\nEases angina symptoms, improving exercise tolerance and daily life quality.\n​\n\nProtects renal function in proteinuric patients by stabilizing vessels.\n​\n\nDosage and Administration\nTake BENIPRIME 4 as 4 mg once daily, swallowed whole after a meal to minimize stomach upset. Doctors may adjust to 2-8mg based on response, age, or kidney/liver status, never exceeding 8 mg daily without monitoring. Consistency in timing ensures steady levels for optimal pressure control.\n​\n\nMissed doses require prompt intake if remembered soon, but skip if near the next one—avoid doubles. Pair with lifestyle changes like low-salt diets and exercise for best results. Always consult for personalization, especially in elderly or comorbid patients.\n​\n\nKey Benefits\nBENIPRIME 4 excels in long-term blood pressure reduction, with studies showing sustained drops in brachial-ankle pulse wave velocity beyond mere pressure effects. It protects the heart and kidneys through anti-sclerotic and antioxidant actions, lowering cardiovascular event risks.\n​\n\nPatients experience fewer angina attacks, better endurance, and improved quality of life. The once-daily regimen boosts adherence, while vascular selectivity minimizes reflex tachycardia common in other blockers. Clinical data indicate reduced C-reactive protein and aldosterone, curbing inflammation and fibrosis.\n​\n\nBenefit\tDescription\tSupporting Evidence\nBP Control\tReduces systolic/diastolic pressure effectively over 24 hours \n​\tLong-term studies show persistent effects post-treatment \n​\nHeart Protection\tImproves coronary flow, cuts angina frequency \n​\tMyocardial protection via NO stimulation \n​\nRenal Support\tLowers proteinuria, aids kidney hypertension \n​\tAnti-oxidative vascular benefits \n​\nAdherence Ease\tOnce-daily dosing with sustained release \n​\tHigh membrane affinity for lasting action \n​\nAdditional perks include potential triglyceride reduction and osteoblast stimulation for bone health in hypertensives.\n\nPotential Side Effects\nMost users tolerate BENIPRIME 4 well, with mild, transient effects resolving spontaneously. Common issues include headache, dizziness, flushing, ankle swelling, palpitations, fatigue, nausea, and sleepiness.\n​\n\nLess frequent are constipation, abdominal pain, tinnitus, shoulder stiffness, urinary frequency, or elevated liver enzymes. Rare serious reactions involve severe hypotension, rash, itching, or allergic responses—seek immediate care if these arise. Monitor blood pressure during initiation to avoid drops.\n\nHeart-related: Palpitations, chest pressure\n​\n\nNervous system: Dizziness, headache\n\nSkin/Vascular: Flushing, edema.\n\nGI: Nausea, constipation\n​\n\nLiver/kidney patients need caution; inform doctors of history.\n\n\nPrecautions and Interactions\nAvoid in hypotension, severe aortic stenosis, or hypersensitivity to dihydropyridines. Use cautiously in liver/kidney impairment, pregnancy, or breastfeeding—benefits must outweigh risks. Grapefruit juice may amplify effects; limit alcohol.\n​\n\nIt interacts with beta-blockers, digoxin, or CYP3A4 inhibitors like ketoconazole, potentially enhancing hypotension. Regular monitoring of BP, electrolytes, and renal function is advised during therapy. Abrupt stop may rebound pressure; taper under guidance.\n​\nConclusion\nBENIPRIME 4 with Benidipine 4 mg empowers reliable hypertension and angina control through innovative calcium channel action. Balancing potent benefits like organ protection and ease of use against manageable side effects, it fits seamlessly into modern cardiac care. Consult healthcare providers for tailored integration with lifestyle for lasting heart health. ", "price": 89.0, "discountamount": 27.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2261, "imageuri": "https://productimages.withfloats.com/actual/6958dbfc615a7d157715572f.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6958dbfc615a7d157715572f.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-03T09:06:02.841Z", "updatedon": "2026-01-03T09:06:02.841Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/benidipine-4mg/2261", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "BENIPRIME 4", "category": "CARDIOLOGYRANGE", "tags": [ "benidipine 4mg", "benidipine 4mg tab", "benidipine hydrochloride uses.", "benidipine.", "benidipine 4 mg", "benidipine 4", "benidipine maximum dose", "benidipine 4 mg uses.", "benidipine price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6948f4ee5837f90c86a7e578", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Elagolix 200mg ", "description": "Eligolux200 contains 200 mg of elagolix per tablet and is manufactured by Steris Healthcare Pvt Ltd in India as a prescription medication in packs of 3x10 tablets. Elagolix acts as a potent gonadotropin-releasing hormone (GnRH) receptor antagonist, binding competitively to GnRH receptors in the pituitary gland to rapidly reduce estrogen and progesterone levels without the initial flare-\nup seen in agonists. This mechanism starves endometrial-like tissue outside the uterus of hormonal stimulation, shrinking lesions and easing inflammation.\n\nAdminister Eligolux200 orally, swallowed whole with water, with or without food, typically starting within 7 days of menstrual onset. Standard dosing for severe cases involves 200mg twice daily for up to 6 months, or 150mg once daily extended to 24 months, adjusted by physicians based on tolerance and response. Store in a cool, dry place away from moisture and light, keeping out of children's reach.\n\nPrimary Uses\nEligolux200 targets moderate to severe endometriosis-associated pain, including dysmenorrhea (painful periods), nonmenstrual pelvic pain, and dyspareunia (painful intercourse). Endometriosis affects millions globally, causing tissue similar to the uterine lining to grow ectopically, leading to chronic inflammation, adhesions, and scarring. By dosing flexibly, Eligolux200 suits patients needing stronger suppression for intense symptoms, reducing reliance on opioids or surgery.\n\nClinical trials like Elaris EM-I and EM-II showed 75% dysmenorrhea reduction and 50-60% nonmenstrual pain relief at 6-12 months. It also curbs heavy menstrual bleeding in uterine fibroids, offering dual benefits for overlapping conditions. Physicians prescribe it when first-line NSAIDs or oral contraceptives fail, prioritizing non-invasive symptom control.\n​\n\nKey Benefits\nEligolix in Eligolux200 delivers rapid pain relief, with significant improvements in daily pain scales within 3 months versus placebo. Women report 47% better composite pelvic pain scores, enhancing daily activities, work productivity, and intimacy. Quality-of-life metrics improve consistently over 24 weeks, including reduced fatigue and better emotional well-being.\n​\n\nUnlike injectables, its oral form and dose-dependent estrogen suppression allow titration—lower doses minimize hypoestrogenic effects while higher 200mg dosing tackles severe pain. Studies confirm amenorrhea in 25% of users early on, slashing bleeding days by up to 50%. Long-term data up to 12 months with add-back therapy sustains efficacy, preserving bone health better than monotherapy. Patients regain control, avoiding invasive laparoscopies and reclaiming normalcy.\n​\n\nBenefit\tEvidence from Trials'\tImpact on Patients\nDysmenorrhea Reduction:\t75% at 6 months \n​\tFewer missed workdays\nNonmenstrual Pain Relief:\t50-60% improvement \n​\tEnhanced mobility\nBleeding Control:\t14% bleeding days vs. 24% baseline \n​\tImproved hygiene, anemia prevention\nQuality of Life\tSustained over 24 weeks \n​\tBetter sleep, relationships\nPotential Side Effects\nCommon side effects of Eligolux200 mirror hypoestrogenic states: hot flashes, night sweats, headache, and nausea, each affecting about 10% of users. These often lessen as the body adjusts, with 69.5% overall adverse event rate over 24 weeks, mostly mild. Mood changes like irritability or depression occur less commonly, warranting mood monitoring.\n​\n\nBone mineral density (BMD) loss poses a key concern—200mg twice daily causes -1.5% to -2.4% drops at lumbar spine and hip after 6 months, attenuated with calcium/vitamin D or add-back therapy. Rare serious risks include suicidal thoughts, liver enzyme elevations, or allergic reactions like anaphylaxis. Discontinuation due to events stays low at 4-12%. No deaths are linked directly to treatment in trials.\n​\n\nSide Effect Category\tFrequency\tManagement\nVasomotor (Hot Flashes)\t9.9-10% \n​\tLifestyle cooling, dose adjustment\nNeurologic (Headache)\t9.9% \n​\tHydration, analgesics\nBone Loss\tUp to 2.4% at 6 months \n​\tDEXA scans, supplements\nMood Changes\tLess common \n​\tPsychiatric screening\nPrecautions and Contraindications\nAvoid Eligolux200 in pregnancy (risk of early loss), known osteoporosis, severe hepatic impairment, or with strong OATP1B1 inhibitors like cyclosporine or gemfibrozil. Women of childbearing age need effective non-hormonal contraception during and 28 days post-therapy, as it impairs recognition of pregnancy via amenorrhea. Not for pediatrics under 18 or geriatrics lacking data.\n\nScreen for depression history, liver function, and BMD before starting; monitor quarterly. Drug interactions abound with rifampin (reduces levels) or over 50 others like clarithromycin—inform physicians fully. Breastfeeding lacks safety data; weigh risks. Regular blood/urine tests track efficacy and safety.\n​\n\nDosage Guidelines\nInitiate Eligolux200 at 150mg daily for milder cases, escalating to 200mg BID for dyspareunia or severe pain, max 6 months at higher dose. Miss a dose? Take promptly unless near the next; never double. Duration caps at 24 months total, with liver-adjusted lower dosing. Pair with add-back for extended use to curb BMD loss.\n​\n\nPhysicians tailor based on response: 74-77% complete 6-month trials. Swallow intact; no crushing.\n​\n\nClinical Evidence\nPhase III trials (Elaris EM-I/II) randomized 1689 women, proving both doses superior to placebo for co-primary endpoints of dysmenorrhea and nonmenstrual pain. Open-label extensions to 24 weeks maintained gains. A 12-month study with add-back showed persistent relief and <1% additional BMD loss versus placebo. Real-world use echoes this, positioning Eligolix as first oral GnRH antagonist approved for endometriosis.\n​\n\nVersus relugolix, Eligolix offers comparable pelvic pain reduction with adjustable dosing. Indian brands like Eligolux200 align with global standards.\n​\n\nConclusion\nEligolux200 transforms endometriosis management, delivering substantial pain relief and functional gains through precise hormonal control. Balancing robust benefits against manageable risks like BMD monitoring empowers women toward symptom-free lives. Consult healthcare providers for personalized integration into care plans.\n", "price": 1000.0, "discountamount": 300.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2251, "imageuri": "https://productimages.withfloats.com/actual/694a2b9f403179ac7e958ef6.png", "tileimageuri": "https://productimages.withfloats.com/tile/694a2b9f403179ac7e958ef6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-22T07:36:14.316Z", "updatedon": "2026-01-02T09:51:07.877Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/elagolix-200mg-/2251", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ELIGOLUX 200", "category": "Gynaecology", "tags": [ "Elagolix Tablets 200mg", "Elagolix acts as a potent gonadotropin-releasing hormone.", "nonmenstrual pelvic pain.", "adhesions, and scarring", "preserving bone health better than monotherapy.", "avoiding invasive laparoscopies and reclaiming normalcy.", "pituitary gland to rapidly reduce estrogen and progesterone.", "tab elagolix 200mg", "elagolix 200mg.", "elagolix.", "elagolix 200.", "elagolix tablets", "elagolix tablets uses.", "elagolix 200 mg price.", "elagolix mechanism of action.", "elagolix 200 mg uses.", "tab elagolixtab elagolix." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6943af86161ad9de85f42b10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "imatinib 400mg", "description": "IMATIFLOW 400, containing Imatinib IP 400mg, represents a breakthrough in targeted cancer therapy, offering patients a precise weapon against specific malignancies. This oral medication belongs to the class of tyrosine kinase inhibitors, revolutionizing treatment for conditions once deemed challenging to manage. By blocking abnormal proteins that fuel cancer cell growth, IMATIFLOW 400 helps restore normal cellular function and improves quality of life for many users.​\n\nProduct Overview\nIMATIFLOW 400 is a branded formulation of Imatinib mesylate 400mg, produced to high pharmaceutical standards for consistent efficacy and bioavailability. Each tablet delivers the active ingredient in a film-coated form, designed for once-daily administration with food to enhance absorption and minimize gastrointestinal upset. Developed for adult patients, it targets cancers driven by dysregulated tyrosine kinases like BCR-ABL, c-KIT, and PDGFR, making it a cornerstone in modern oncology protocols.​\n\nThe medication's mechanism hinges on competitive inhibition at the ATP-binding site of these kinases, halting downstream signaling pathways that promote uncontrolled proliferation, survival, and metastasis of malignant cells. Unlike traditional chemotherapy, which broadly attacks dividing cells, IMATIFLOW 400 spares most healthy tissues, leading to a more favorable safety profile. Clinical data from pivotal trials underscore its role as first-line therapy, with high response rates observed within months of initiation.​\n\nPrimary Uses\nIMATIFLOW 400 excels in treating chronic myeloid leukemia (CML), particularly in the chronic phase where it induces deep molecular responses in over 80% of patients. It suppresses the Philadelphia chromosome-positive cells hallmark of CML by inhibiting the BCR-ABL fusion protein, dramatically extending progression-free survival. For newly diagnosed patients, standard dosing starts at 400mg daily, often achieving complete cytogenetic remission.​\n\nIn gastrointestinal stromal tumors (GIST), IMATIFLOW 400 targets KIT or PDGFRA mutations, shrinking unresectable tumors and delaying progression in advanced cases. The recommended dose remains 400mg once daily, with potential escalation to 600-800mg for resistant strains, as per oncology guidelines. It also finds application in dermatofibrosarcoma protuberans (DFSP), aggressive systemic mastocytosis, and certain myelodysplastic syndromes, broadening its utility in precision medicine.​\n\nHealthcare providers monitor response via PCR for BCR-ABL transcripts in CML or imaging for GIST, adjusting therapy based on milestones like major molecular response. Patients with Ph+ acute lymphoblastic leukemia (ALL) may receive it adjunctively, enhancing outcomes when combined with chemotherapy. Overall, IMATIFLOW 400 transforms these diseases from fatal to chronically manageable.​\n\nKey Benefits\nOne standout benefit of IMATIFLOW 400 is its oral convenience, eliminating the need for frequent hospital visits associated with infusions. Response rates exceed 90% in early CML, with many patients achieving treatment-free remission after sustained deep responses, a paradigm shift from interferon-era therapies.​\n\nTumor control in GIST prevents life-threatening complications like bowel obstruction, improving survival from months to years. Its specificity reduces severe toxicities, allowing patients to maintain daily activities, work, and social engagements with minimal disruption. Long-term studies report 10-year survival rates above 80% in CML, underscoring durable efficacy.​\n\nAdditional advantages include cost-effectiveness over biologics and compatibility with supportive care like hydroxyurea for cytoreduction. Fluid retention, while common, responds well to diuretics, preserving cardiac function. For Indian patients, accessible pricing via brands like IMATIFLOW 400 supports equitable care in resource-limited settings.​\n\nPotential Side Effects\nWhile generally well-tolerated, IMATIFLOW 400 can cause edema (swelling in legs or face) in up to 70% of users, managed by dose reduction or supportive measures. Gastrointestinal issues like nausea, vomiting, and diarrhea affect 40-50%, often resolving with antiemetics and dietary adjustments.​\n\nMusculoskeletal pain, cramps, and fatigue occur frequently, alongside rash and abdominal discomfort. Hematologic effects include neutropenia or thrombocytopenia, necessitating regular blood counts. Rare but serious risks involve liver enzyme elevation, heart failure, or hemorrhage; prompt reporting of symptoms like shortness of breath or yellowing skin is crucial.​\n\nAvoid grapefruit juice, as it elevates drug levels, and inform doctors of concurrent medications like CYP3A4 inhibitors. Pregnancy category D status advises contraception, with monitoring for growth retardation in exposed fetuses. Dizziness may impair driving, so caution is essential during initial weeks.​\n\nDosage and Administration Guidelines\nSwallow IMATIFLOW 400 whole with a meal and full glass of water to optimize pharmacokinetics and reduce esophageal irritation. The standard adult dose for CML chronic phase is 400mg daily; for accelerated phase or blast crisis, 600mg. GIST dosing mirrors 400mg, titrated based on tolerance and response.​\n\nRenal or hepatic impairment requires dose adjustments—reduce to 300-400mg in moderate cases. Do not crush or chew tablets. Missed doses should be taken promptly unless near the next, avoiding doubles. Long-term use demands quarterly monitoring of CBC, liver function, and ECG.​\n\nPrecautions and Interactions\nPatients with a cardiac history need baseline echocardiograms, as QT prolongation or effusion risks exist. Drug interactions abound: St. John's wort induces metabolism, reducing efficacy; ketoconazole boosts levels. Vaccines, especially live ones, are contraindicated during therapy.​\n\nRegular dermatologic checks mitigate skin cancer risk from prolonged use. Hydration combats fluid retention, and low-salt diets aid management. Steris Healthcare emphasizes patient education via counseling on adherence for optimal outcomes.​\n\nConclusion\nIMATIFLOW 400 (Imatinib IP 400mg) stands as a testament to targeted therapy's power, offering robust control over CML, GIST, and related cancers with a balance of efficacy and manageability. Its benefits in prolonging life and enhancing daily functioning far outweigh transient side effects for most when monitored diligently. Consult oncologists for personalized plans, ensuring this innovative treatment maximizes hope and health in the fight against cancer.", "price": 1827.0, "discountamount": 540.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2249, "imageuri": "https://productimages.withfloats.com/actual/6943b026ca1b0dcfc6c37820.png", "tileimageuri": "https://productimages.withfloats.com/tile/6943b026ca1b0dcfc6c37820.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-18T07:38:46.766Z", "updatedon": "2026-01-08T07:15:13.88Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/imatinib-400mg/2249", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IMATIFLOW 400", "category": "NEPHROLOGYRANGE", "tags": [ "Imatinib IP 400mg", "offering robust control over CML.", "related cancers with a balance of efficacy and manageability.", "innovative treatment maximizes hope and health in the fight against cancer.", "cancer therapy.", "fuel cancer cell growth.", "chemotherapy.", "imatinib 400mg.", "imatinib 400mg tablet.", "tab. imatinib 400mg.", "imatinib 400mg price.", "imatinib 400mg tab", "imatinib 400mg side effects.", "imatinib 400 mg tablet", "imatinib 400 mg medicine", "imatinib tablets 400 mg uses", "imatinib 400 mg dosage", "imatinib 400 mg price in india", "imatinib 400 mg brand name" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "693c0c9c0c30ac5c9f8203b4", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Isosorbide Mononitrate IP 30mg Tablets", "description": "CARDULES ISMN SR 30 tablets provide sustained-release Isosorbide Mononitrate IP 30mg, a nitrate medication designed for long-term management of angina in patients with coronary artery disease. This formulation from Steris Healthcare Pvt Ltd ensures steady vasodilation to improve heart blood flow and reduce chest pain episodes. It supports daily activities by minimizing oxygen demand on the heart muscle.​\nProduct Overview\nCARDULES ISMN SR 30 contains Isosorbide Mononitrate IP 30mg in a sustained-release matrix, allowing once-daily dosing for consistent therapeutic levels over 12-24 hours. The tablet's extended-release technology prevents peak-trough fluctuations common in immediate-release forms, promoting better patient compliance. Each film-coated tablet delivers precise bioavailability, with the active metabolite nitric oxide activating guanylate cyclase to boost cyclic GMP, relaxing vascular smooth muscle primarily in veins.​\n\nThis mechanism reduces preload (venous return to the heart) and afterload (arterial resistance), easing cardiac workload without significantly affecting heart rate. Unlike short-acting nitrates for acute relief, CARDULES ISMN SR 30 targets prophylaxis in chronic stable angina, often prescribed alongside beta-blockers or calcium channel blockers. Available in strips of 10 tablets, it undergoes rigorous quality testing at Steris facilities to meet IP standards, ensuring purity and stability.​\n\nKey Uses\nCARDULES ISMN SR 30 primarily prevents angina pectoris in coronary artery disease, where narrowed vessels limit oxygen supply during exertion. Patients experience fewer chest pain attacks during walking, climbing stairs, or stress.​\n\nIt manages chronic stable angina by enhancing myocardial perfusion, suitable for long-term therapy in adults over 18. Healthcare providers may use it adjunctively for coronary spasm or post-myocardial infarction prophylaxis to stabilize symptoms.​\n\nIn select cases, it aids heart failure management by offloading the heart, though not as monotherapy. Always initiate under cardiology supervision with dose titration to tolerance.​\n\nMajor Benefits\nThe sustained-release profile offers 24-hour protection with single morning dosing, improving adherence and lifestyle quality for active patients. It boosts exercise tolerance by 20-30% in trials, allowing longer physical efforts without angina onset.​\n\nBy dilating vessels, it decreases ischemia risk, potentially lowering hospitalization rates for acute episodes. Compared to placebo, users report halved attack frequency within weeks, enhancing daily productivity and emotional well-being.​\n\nBenefit\tMechanism\tPatient Outcome\nAngina Prevention\tVasodilation reduces preload/afterload ​\tFewer attacks, better exertion capacity\nSteady Relief\tSR formulation maintains levels ​\tOnce-daily convenience, no fluctuations\nHeart Protection\tImproves O2 delivery ​\tReduced ischemia, enhanced QoL\nCompliance Boost\tSimple regimen ​\tHigher adherence vs multiple doses\nAdditional perks include minimal impact on blood pressure in normotensives and compatibility with anti-anginals, making it versatile in combo therapy.\n\nPotential Side Effects\nCommon effects include headache (dose-related, often transient in first week), dizziness, or flushing due to vasodilation—hydrate and rise slowly to manage. Gastrointestinal upset like nausea occurs in 5-10% initially.​\n\nOrthostatic hypotension risks fainting, especially early; avoid alcohol or other vasodilators. Rare serious issues encompass severe hypotension, tachycardia, or methemoglobinemia with overdose—monitor blood pressure regularly.​\n\nAllergic reactions (rash, itching) or vision changes warrant discontinuation. Contraindicated in hypotension, glaucoma, or recent PDE5 inhibitor use; caution in anemia or hypothyroidism.​\n\nDosage Guidelines\nStart with 30mg once daily upon waking, swallowed whole without crushing. Titrate to 60mg if tolerated after 3-7 days, max 120mg/day. Take on empty stomach for optimal absorption; avoid late dosing to prevent nocturnal headaches.​\n\nAdjust for elderly or renal/hepatic impairment. Tolerance may develop—nitrate-free interval (evening) helps sustain efficacy. Store below 30°C.​\nConclusion\nCARDULES ISMN SR 30 empowers angina patients with reliable, once-daily prevention, restoring confidence in routine activities under Steris Healthcare's quality assurance. Its targeted vasodilation balances efficacy and tolerability for sustained heart health", "price": 65.0, "discountamount": 19.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2243, "imageuri": "https://productimages.withfloats.com/actual/693c0ca6391a3fa44b0608d8.png", "tileimageuri": "https://productimages.withfloats.com/tile/693c0ca6391a3fa44b0608d8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-12T12:37:48.92Z", "updatedon": "2025-12-12T12:37:48.92Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/isosorbide-mononitrate-ip-30mg-tablets/2243", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CARDULES ISMN SR 30", "category": "", "tags": [ "Isosorbide Mononitrate IP 30mg Tablets", "coronary artery disease", "heart blood flow and reduce chest pain episodes", "oxygen demand on the heart muscle", "relaxing vascular smooth muscle primarily in veins" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "693c05831844c6739ab3e83a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Mefenamic Acid and Paracetamol Suspension", "description": "METAPECT MF KID SUSPENSION stands out as a specialized formulation from Steris Healthcare Pvt Ltd, blending Mefenamic Acid, a non-steroidal anti-inflammatory drug (NSAID), with Paracetamol, a widely used analgesic and antipyretic. Typically available in a 60ml bottle with child-friendly flavoring, it contains precise concentrations like 100mg Mefenamic Acid and 250mg Paracetamol per 5ml serving, ensuring accurate dosing via the included measuring cup. This sugar-free or low-sugar variant minimizes dental risks while providing rapid absorption for faster onset compared to solid forms. Manufactured under stringent quality controls, it supports pediatric care by addressing inflammation at its source through COX enzyme inhibition, which curbs prostaglandin production responsible for pain signals and fever response.​\n\nThe suspension's dual-action mechanism sets it apart: Paracetamol targets the brain's hypothalamus to regulate body temperature and elevate pain thresholds, while Mefenamic Acid reduces tissue swelling and inflammatory mediators. This synergy makes METAPECT MF KID SUSPENSION more effective than single-ingredient options for multifaceted symptoms. Healthcare professionals often recommend it for short-term use in infants over six months and children, always under medical guidance to match age and weight-based dosages.​\n\nKey Uses\nMETAPECT MF KID SUSPENSION excels in managing fever associated with viral infections, teething, or post-vaccination reactions. It swiftly lowers elevated temperatures, promoting comfort and better sleep for restless kids.​\n\nFor pain relief, it tackles mild to moderate discomfort from headaches, toothaches, earaches, and sore throats common during colds or flu. Caregivers report noticeable easing of symptoms within 30-60 minutes, allowing children to resume play or eat without distress.​\n\nAdditionally, it soothes body aches, muscle strains from minor injuries, or joint pains in growing kids. In cases of post-surgical recovery or inflammatory episodes, it provides reliable support without the need for stronger opioids.​\n\nMajor Benefits\nThe primary benefit lies in its comprehensive symptom control, combining antipyretic, analgesic, and anti-inflammatory effects for holistic relief. Children experience reduced fever, less pain, and diminished swelling, leading to improved appetite and activity levels.​\n\nIts liquid suspension format ensures easy administration—no choking risks—and precise dosing prevents under- or overdosing. Flavored options like mango enhance compliance, turning medicine time into a less daunting routine for picky eaters.​\n\nCompared to alternatives, METAPECT MF KID SUSPENSION offers quicker bioavailability due to its oral liquid state, ideal for emergencies like high fever spikes at night. Long-term, it supports faster recovery by minimizing inflammation, potentially shortening illness duration when used as directed.​\n\nBenefit\tDescription:\tAdvantage over Single Agents\nFever Reduction\tLowers temperature via hypothalamic action ​\tFaster than Paracetamol alone\nPain Relief\tBlocks pain signals and prostaglandins. ​\tSuperior for inflammatory pain\nAnti-Inflammatory\tReduces swelling in tissues ​\tAddresses root cause, not just symptoms\nEasy Dosing\tLiquid with dropper for accuracy ​\tChild-friendly, no splitting tablets\nPotential Side Effects\nWhile generally well-tolerated, METAPECT MF KID SUSPENSION may cause mild gastrointestinal issues like nausea, vomiting, stomach pain, or indigestion in some children, especially if taken on an empty stomach. Administering with food can mitigate this.​\n\nLess common effects include drowsiness, dizziness, or allergic reactions such as rashes, itching, or swelling—seek immediate medical help if these occur. Prolonged use risks liver strain from Paracetamol or kidney concerns from Mefenamic Acid, so adhere strictly to prescribed durations.​\nRarely, it might lead to diarrhea, headache, or elevated liver enzymes. Monitoring is key; consult a doctor for persistent symptoms or in kids with pre-existing conditions like asthma or ulcers.​\n\nDosage Guidelines\nFollow pediatrician-recommended doses based on weight: typically 5-10ml every 6-8 hours, not exceeding 4 doses daily. Shake well before use and store below 30°C away from light.​\nAvoid in neonates under 6 months or those with hypersensitivity. Hydration and diet play roles in efficacy—pair with plenty of fluids.​\nConclusion\nMETAPECT MF KID SUSPENSION empowers parents with a dependable tool for childhood pain and fever, blending efficacy, safety, and convenience under Steris Healthcare's trusted banner. Quick relief restores normalcy, but professional oversight ensures optimal outcomes.", "price": 57.0, "discountamount": 18.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2241, "imageuri": "https://productimages.withfloats.com/actual/693c05860443b6722a4db029.png", "tileimageuri": "https://productimages.withfloats.com/tile/693c05860443b6722a4db029.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-12T12:07:31.874Z", "updatedon": "2026-01-08T08:06:57.343Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/mefenamic-acid-and-paracetamol-suspension/2241", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "METAPECT MF KID SUSPENSION", "category": "PEDIATRICS", "tags": [ "Mefenamic Acid and Paracetamol Suspension", "Paracetamol", "Mefenamic Acid and 250mg Paracetamol per 5ml serving", "COX enzyme inhibition", "pain and fever", "Pain Relief", "mefenamic acid.", "mefenamic acid tablet uses.", "mefenamic acid and paracetamol suspension.", "mefenamic acid suspension.", "paracetamol and mefenamic acid suspension.", "mefenamic acid and paracetamol suspension uses." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68beb577cb617ef27c577d94", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "cefpodoxime proxetil oral suspension ip 50 mg", "description": "CEPHODOXIAA 50 DS is an oral suspension containing Cefpodoxime Proxetil, a third-generation cephalosporin antibiotic. It is widely prescribed for the treatment of bacterial infections in adults and children, including infants and babies.Oral suspension form is particularly useful for children and patients who have difficulty swallowing tablets, ensuring accurate dosing and better compliance.\nComposition\nActive Ingredient: Cefpodoxime Proxetil 50 mg per 5 ml suspension\nBrand Name: CEPHODOXIAA 50 DS\nForm: Oral Suspension\nDrug Class: Cephalosporin Antibiotic\nExcipients: Flavors, sweeteners, stabilizers for palatability and suspension stability\nCefpodoxime Proxetil Oral Suspension IP Uses\nCEPHODOXIAA 50 DS is prescribed for a wide variety of bacterial infections:\nRespiratory Tract Infections\nTonsillitis, Pharyngitis\nBronchitis and Pneumonia\nEar, Nose & Throat (ENT) Infections\nAcute Sinusitis\nOtitis Media (middle ear infection)\nUrinary Tract Infections (UTIs)\nCystitis and kidney infections\nSkin & Soft Tissue Infections\nImpetigo, Cellulitis\nInfected wounds and abscesses\nOther Indications\nGonorrhea (in selected cases)\nPediatric bacterial infections where oral dosing is preferred\nFor babies and children: The oral suspension allows precise weight-based dosing, making it safe and convenient for pediatric infections.\nHow Cefpodoxime Proxetil Oral Suspension Works\nCefpodoxime Proxetil is a beta-lactam antibiotic that:\nInhibits bacterial cell wall synthesis\nWeakens bacterial cells, causing cell death\nEffective against both Gram-positive and Gram-negative bacteria\nThis mechanism helps control infections and prevents their spread.\nDosage & Administration \nInfants & Children: Dose is based on body weight and prescribed by a pediatrician.\nCommonly 5–10 mg/kg/day, divided into 2 doses daily.\nAdults: Typically 100–200 mg every 12 hours, depending on infection severity.\nAdministration Tips:\nShake the bottle well before use.\nUse the measuring cup or spoon provided for accurate dosing.\nCan be taken with or without food, but giving after meals may reduce stomach upset.\nComplete the full course even if symptoms improve.\nBenefits of Cefpodoxime Proxetil Oral Suspension\nEasy to administer for children and babies\nBroad-spectrum coverage for respiratory, urinary, and skin infections\nHelps in rapid infection control\nSafe and effective with minimal side effects when taken as prescribed\nSuspension form allows accurate weight-based dosing\nSide Effects of Cefpodoxime Proxetil Oral Suspension\nMild side effects may include:\nDiarrhea or loose stools\nNausea or vomiting\nStomach pain\nHeadache or dizziness\nSkin rash or itching\nSerious side effects (rare):\nSevere allergic reaction (swelling, rash, difficulty breathing)\nSevere diarrhea indicating Clostridium difficile infection\nLiver enzyme elevation\nSeek medical attention if any severe or persistent side effects occur.\nPrecautions & Warnings\nAvoid if allergic to cephalosporins, penicillin, or other beta-lactam antibiotics\nUse cautiously in patients with kidney or liver disease\nNot effective against viral infections like flu or common cold\nPregnant or breastfeeding women should consult a doctor before use\nAlways complete the full prescribed course to prevent antibiotic resistance\nDrug Interactions\nAntacids containing magnesium or aluminum may reduce absorption\nProton pump inhibitors (PPIs) like omeprazole\nBlood thinners (e.g., warfarin – monitor for increased bleeding risk)\nOther antibiotics may interact and alter effectiveness\nConclusion\nCEPHODOXIAA 50 DS (Cefpodoxime Proxetil Oral Suspension IP) is a safe and effective solution for treating bacterial infections in adults, children, and babies.", "price": 100.0, "discountamount": 30.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2178, "imageuri": "https://productimages.withfloats.com/actual/68beb57bed36b14275f756c2.png", "tileimageuri": "https://productimages.withfloats.com/tile/68beb57bed36b14275f756c2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-08T10:52:39.162Z", "updatedon": "2025-12-09T06:13:04.25Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cefpodoxime-proxetil-oral-suspension-ip-50-mg/2178", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CEPHODOXIAA 50 DS", "category": "Pediatric", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66d99766d075bc6e1b960947", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "glycopyrrolate glycopyrronium inhalation solution 25 mcg", "description": "GLYCOPRESS \nglycopyrrolate glycopyrronium inhalation solution 25 mcg \nGLYCOPRESS™ is a precision-formulated inhalation solution containing 25 mcg of glycopyrrolate (also known as glycopyrronium), a long-acting bronchodilator designed to help individuals manage chronic respiratory conditions. Glycopyrrolate belongs to a class of medications known as long-acting muscarinic antagonists (LAMAs). These medicines work by relaxing the muscles surrounding the airways, allowing them to remain open for easier breathing.\n\nGLYCOPRESS™ is primarily prescribed for the maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is intended for regular, long-term use and is delivered via a nebulizer system, ensuring consistent and controlled medication delivery directly into the lungs.\n\nThis inhalation solution is developed to provide sustained bronchodilation, improved airflow, and enhanced respiratory comfort for patients who require ongoing airway management.\n\nHow GLYCOPRESS™ Works\n\nThe active ingredient in GLYCOPRESS™, glycopyrrolate, works by blocking the action of acetylcholine at muscarinic receptors in the bronchial smooth muscle. Acetylcholine is a neurotransmitter that causes airway muscles to constrict. By inhibiting its action, glycopyrrolate helps prevent bronchospasm (tightening of the airway muscles).\n\nThis mechanism results in:\n\nRelaxation of bronchial smooth muscles\n\nReduced airway resistance\n\nImproved airflow\n\nEasier breathing\n\nAs a long-acting bronchodilator, GLYCOPRESS™ provides sustained airway dilation, making it suitable for daily maintenance therapy rather than immediate relief of sudden breathing problems.\n\nIndications and Uses\n\nGLYCOPRESS™ is indicated for:\n\nMaintenance treatment of chronic obstructive pulmonary disease (COPD)\n\nManagement of chronic bronchitis\n\nManagement of emphysema\n\nLong-term bronchodilation therapy\n\nIt is important to note that GLYCOPRESS™ is not a rescue medication. It should not be used for sudden episodes of shortness of breath. Patients should continue to carry a fast-acting rescue inhaler for acute bronchospasm episodes.\n\nKey Benefits of GLYCOPRESS™\n1. Long-Lasting Bronchodilation\n\nGLYCOPRESS™ provides sustained airway relaxation, helping maintain open airways throughout the day when used as prescribed.\n\n2. Improved Breathing Comfort\n\nBy reducing airway constriction, patients often experience reduced shortness of breath, wheezing, and chest tightness.\n\n3. Enhanced Lung Function\n\nRegular use may lead to measurable improvements in lung capacity and airflow over time.\n\n4. Reduced Exacerbations\n\nConsistent bronchodilation can help lower the frequency and severity of COPD flare-ups.\n\n5. Convenient Nebulized Delivery\n\nThe inhalation solution format ensures medication reaches deep into the lungs, especially beneficial for patients who struggle with handheld inhalers.\n\n6. Targeted Action\n\nBecause the medication is inhaled directly into the lungs, systemic exposure is minimized compared to oral medications, potentially reducing widespread side effects.\n\n7. Non-Steroidal Option\n\nGLYCOPRESS™ does not contain corticosteroids, making it suitable for patients seeking bronchodilation without steroid exposure.\n\nDosage and Administration\n\nGLYCOPRESS™ (25 mcg) should be used exactly as prescribed by a healthcare professional. The inhalation solution is administered via a standard nebulizer device.\n\nGeneral usage guidelines:\n\nUse at the same time each day.\n\nDo not exceed the prescribed dose.\n\nDo not swallow the solution.\n\nRinse the mouth after inhalation if advised by your healthcare provider.\n\nClean the nebulizer equipment after each use to maintain hygiene and prevent contamination.\n\nPatients should never abruptly discontinue therapy without consulting their healthcare provider.\n\nPossible Side Effects\n\nLike all medications, GLYCOPRESS™ may cause side effects. While many patients tolerate glycopyrrolate well, some may experience mild to moderate reactions.\n\nCommon Side Effects\n\nDry mouth\n\nThroat irritation\n\nCough\n\nHeadache\n\nNasal congestion\n\nMild dizziness\n\nThese effects are usually manageable and may decrease as the body adjusts to the medication.\n\nLess Common but Serious Side Effects\n\nDifficulty urinating\n\nBlurred vision\n\nIncreased heart rate (tachycardia)\n\nWorsening of glaucoma symptoms\n\nSevere allergic reactions (rash, swelling, difficulty breathing)\n\nPatients with a history of narrow-angle glaucoma, urinary retention, or prostate enlargement should use GLYCOPRESS™ with caution and under medical supervision.\n\nIf sudden worsening of breathing occurs immediately after use (paradoxical bronchospasm), discontinue the medication and seek medical attention immediately.\n\nPrecautions and Warnings\n\nBefore starting GLYCOPRESS™, inform your healthcare provider if you:\n\nHave glaucoma\n\nHave urinary retention issues\n\nHave prostate enlargement\n\nHave kidney problems\n\nAre pregnant or breastfeeding\n\nAre using other anticholinergic medications\n\nDrug interactions may occur when used alongside other anticholinergic drugs, potentially increasing side effects such as dry mouth or urinary retention.\n\nGLYCOPRESS™ should be stored at room temperature and kept away from direct sunlight and moisture. Keep out of reach of children.\n\nWho Should Use GLYCOPRESS™?\n\nGLYCOPRESS™ is suitable for adults diagnosed with chronic obstructive pulmonary disease who require consistent, long-term airway management. It is particularly beneficial for:\n\nPatients who experience persistent daily symptoms\n\nIndividuals who require nebulized medication delivery\n\nPatients needing a non-steroidal maintenance bronchodilator\n\nThose seeking improved respiratory stability and quality of life\n\nIt is not recommended for pediatric patients unless specifically directed by a healthcare professional.\n\nQuality and Reliability\n\nGLYCOPRESS™ is manufactured under strict pharmaceutical quality standards to ensure consistent dosing accuracy, sterility, and safety. Each 25 mcg dose is carefully formulated to deliver precise bronchodilation while minimizing systemic absorption.\n\nIts inhalation solution format ensures even dispersion and efficient lung deposition when used with an appropriate nebulizer system.\n\nLifestyle Support with GLYCOPRESS™\n\nWhile GLYCOPRESS™ plays a critical role in COPD management, optimal results are achieved when combined with:\n\nSmoking cessation\n\nPulmonary rehabilitation programs\n\nRegular exercise as advised\n\nBalanced nutrition\n\nRoutine medical follow-up\nPatients are encouraged to monitor symptoms regularly and maintain open communication with their healthcare provider.\nConclusion\nGLYCOPRESS™ (Glycopyrrolate / Glycopyrronium Inhalation Solution 25 mcg) represents a reliable, long-acting bronchodilator option for individuals managing chronic obstructive pulmonary disease. By targeting airway muscle constriction at its source, GLYCOPRESS™ promotes sustained bronchodilation, improved airflow, and enhanced breathing comfort.", "price": 2250.0, "discountamount": 675.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "2 ml", "1 ml", "25 mcg", "Dry Mouth", "single dose", "fast relief", "gut motility", "higher doses", "stomach acid", "Key Benefits", "clear airways", "long-term use", "bodily fluids", "natural fluids", "rare instances", "potential risks", "fast heart rate", "mucus production", "Preoperative Use", "saliva production", "Glycopyrrolate IP", "Urinary Retention", "clinical settings", "saliva substitutes", "specific condition", "healthcare provider", "common side effects", "respiratory diseases", "muscarinic receptors", "glandular secretions", "Respiratory Function", "excessive secretions", "Increased Heart Rate", "optimal effectiveness", "2ml isotonic solution", "Isotonic solution 2ml", "respiratory conditions", "Convenient Dosage Form", "anticholinergic effects", "intramuscular injection", "healthcare professional", "other bodily secretions", "effective administration", "Temporary blurred vision", "various medical conditions", "specialized pharmaceutical solution" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1970, "imageuri": "https://productimages.withfloats.com/actual/66d99795d84b3a29c4a85529.png", "tileimageuri": "https://productimages.withfloats.com/tile/66d99795d84b3a29c4a85529.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-05T11:35:02.018Z", "updatedon": "2026-02-17T07:16:44.673Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glycopyrrolate-glycopyrronium-inhalation-solution-25-mcg/1970", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLYCOPRESS ", "category": "ASTHMARANGE", "tags": [ "glycopyrrolate glycopyrronium inhalation solution 25 mcg single dose vial", "glycopyrrolate glycopyrronium 25 mcg nebulizer solution for COPD", "glycopyrrolate 25 mcg inhalation solution unit dose ampule", "glycopyrrolate 25 mcg nebulized bronchodilator therapy", "glycopyrrolate inhalation 25 mcg dosing instructions", "glycopyrrolate 25 mcg inhalation solution prescribing information", "what is glycopyrrolate glycopyrronium inhalation solution 25 mcg used for", "what is glycopyrrolate glycopyrronium inhalation solution 25 mcg used for", "is glycopyrronium 25 mcg inhalation solution safe for COPD", "can glycopyrrolate 25 mcg inhalation solution cause dry mouth", "buy glycopyrrolate glycopyrronium inhalation solution 25 mcg online" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }